A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB Pharma Inc
- 16 Jul 2007 Status change from in progress to completed.
- 30 Sep 2006 New trial record.